Gonzalez-Cortes, J.H.; Gonzalez-Cantu, J.E.; Bilgic, A.; March de Ribot, F.; Sudhalkar, A.; Kodjikian, L.; Pelayes, D.; Mathis, T.; Mohamed-Hamsho, J.
Beyond Anti-VEGF: Toward Integrated Precision Care in Diabetic Retinal Disease. Pharmaceutics 2026, 18, 1178.
https://doi.org/10.3390/pharmaceutics18091178
AMA Style
Gonzalez-Cortes JH, Gonzalez-Cantu JE, Bilgic A, March de Ribot F, Sudhalkar A, Kodjikian L, Pelayes D, Mathis T, Mohamed-Hamsho J.
Beyond Anti-VEGF: Toward Integrated Precision Care in Diabetic Retinal Disease. Pharmaceutics. 2026; 18(9):1178.
https://doi.org/10.3390/pharmaceutics18091178
Chicago/Turabian Style
Gonzalez-Cortes, Jesus H., Jesus E. Gonzalez-Cantu, Alper Bilgic, Francesc March de Ribot, Aditya Sudhalkar, Laurent Kodjikian, David Pelayes, Thibaud Mathis, and Jesus Mohamed-Hamsho.
2026. "Beyond Anti-VEGF: Toward Integrated Precision Care in Diabetic Retinal Disease" Pharmaceutics 18, no. 9: 1178.
https://doi.org/10.3390/pharmaceutics18091178
APA Style
Gonzalez-Cortes, J. H., Gonzalez-Cantu, J. E., Bilgic, A., March de Ribot, F., Sudhalkar, A., Kodjikian, L., Pelayes, D., Mathis, T., & Mohamed-Hamsho, J.
(2026). Beyond Anti-VEGF: Toward Integrated Precision Care in Diabetic Retinal Disease. Pharmaceutics, 18(9), 1178.
https://doi.org/10.3390/pharmaceutics18091178
